HBME1 was found to be the most sensitive marker of thyroid malignancy by Palo et al. [50], followed by CK19, in differentiating FVPTC from FA and follicular carcinoma. This evidence concerns the gene KRT19 and follicular variant thyroid gland papillary carcinoma.